Beneficient (BENFW) EBIT (2021 - 2025)

Beneficient's EBIT history runs 5 years deep, the most recent figure standing at $3.9 million for Q4 2025.

• In Q4 2025, EBIT rose 141.46% year-over-year to $3.9 million; the TTM figure through Dec 2025 stood at -$148.4 million (up 12.4% YoY), while the FY2025 annual figure was -$24.2 million, up 99.09% from the prior year.
• EBIT came in at $3.9 million for Q4 2025 at Beneficient, up from -$17.9 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $48.6 million in Q2 2024 to a low of -$1.2 billion in Q2 2023.
• A 5-year average of -$211.0 million and a median of -$59.1 million in 2022 frame the typical range for EBIT.
• Across the five-year window, EBIT sank 1244.92% in 2023 and soared 141.46% in 2025, its largest moves.
• Beneficient's EBIT stood at -$23.2 million in 2021, then slumped by 214.15% to -$73.0 million in 2022, then plunged by 1154.73% to -$916.0 million in 2023, then jumped by 98.96% to -$9.5 million in 2024, then jumped by 141.46% to $3.9 million in 2025.
• According to Business Quant data, EBIT over the past three periods registered $3.9 million, -$17.9 million, and -$89.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison